At a glance
- Current status: Open
- Fund type: EIS
- Investment goal: Capital growth
- Focus: Industrial High-Tech
- Target returns: 3x
- Target holding period: 5 years
- Minimum subscription: £10,000
The EMVC Evergreen EIS Fund's objective is to invest in technologies that are driving the advancement of British industrial high-tech. EMVC’s team has been investing in and growing UK and international B2B businesses, with a particular focus on technologies with industrial high-tech applications, including robotics, artificial intelligence, machine vision, power electronics, internet of things and materials science.
EMVC has a strong infrastructure for sourcing, evaluating, investing in and supporting companies with this profile, leveraging its network of private and institutional investors, corporate partners, and industry experts.
Investment Strategy
EMVC Evergreen EIS Fund will specialise in B2B technology including industrial high-tech, energy, robotics and AI, IoT and resource efficiency. EMVC’s strategy is built on three key pillars:
-
Real businesses, real innovation, real value: The Fund will only invest in B2B businesses built on core technological innovation.
-
Strong corporate links: The Fund will seek to leverage EMVC’s network of corporate relationships both to validate the opportunities and to accelerate the growth of the Investee Companies.
-
Follow on capital and co-investment: The Fund will seek to benefit from EMVC’s access to follow-on funding, such as through EMVC’s contacts with institutional investors, corporate venturing teams and investment vehicles.
EIS tax incentives
The companies the fund invest in are expected to be EIS-qualifying, which makes British Ventures EIS suitable for qualifying clients who would potentially benefit from the following tax reliefs:
- Up to 30% income tax relief
- Tax-free investment growth
- Capital gains deferral
- Inheritance tax relief
- Loss relief
Please note: EIS tax reliefs are only made available to investors because of the higher risks associated with investing in early-stage companies. Also, the availability of tax reliefs will depend on the investor's personal circumstances, and tax legislation can change in the future.
Example companies from the current fund portfolio
SageTech is disrupting the anaesthesia industry with a patented platform technology that captures, extracts, and purifies volatile anaesthetic agents. These anaesthetics are significant greenhouse gases, which SageTech can prevent from ever reaching the atmosphere, whilst providing cost savings for hospitals through a new circular economy.
Q-Bot is disrupting the construction industry by providing a robotic service and digitisation platform technology. Q-Bot’s first application of semi-automated under-floor insulation using robotic devices is reducing the duration of such a project from 2+ weeks down to 1-2 days.
Sofant is developing a low cost RF MEMS technology that solves power consumption and heat problems in high frequency phased array antenna systems.
.svg)